161 related articles for article (PubMed ID: 37577021)
21. Promoter Methylation of Cancer Stem Cell Surface Markers as an Epigenetic Biomarker for Prognosis of Oral Squamous Cell Carcinoma.
Han YK; Park HY; Park SG; Hwang JJ; Park HR; Yi JM
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498950
[TBL] [Abstract][Full Text] [Related]
22. [Aberrant methylation of tumor suppressor genes in head and neck squamous cell carcinoma: is it clinically relevant?].
Righini CA; de Fraipont F; Reyt E; Favrot MC
Bull Cancer; 2007 Feb; 94(2):191-7. PubMed ID: 17337388
[TBL] [Abstract][Full Text] [Related]
23. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
24. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma.
Strzelczyk JK; Krakowczyk Ł; Owczarek AJ
Arch Oral Biol; 2019 Feb; 98():265-272. PubMed ID: 30576962
[TBL] [Abstract][Full Text] [Related]
25. Methylation of tumour suppressor genes associated with thyroid cancer.
Botezatu A; Iancu IV; Plesa A; Manda D; Popa O; Bostan M; Mihaila M; Albulescu A; Fudulu A; Vladoiu SV; Huica I; Dobrescu R; Anton G; Badiu C
Cancer Biomark; 2019; 25(1):53-65. PubMed ID: 31006665
[TBL] [Abstract][Full Text] [Related]
26. Homeobox gene amplification and methylation in oral squamous cell carcinoma.
Rodrigues MFSD; Xavier FCA; Esteves CD; Nascimento RB; Nobile JS; Severino P; de Cicco R; Toporcov TN; Tajara EH; Nunes FD
Arch Oral Biol; 2021 Sep; 129():105195. PubMed ID: 34126417
[TBL] [Abstract][Full Text] [Related]
27. The role of p300 in the tumor progression of oral squamous cell carcinoma.
Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
[TBL] [Abstract][Full Text] [Related]
28. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
29. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic repression of HOXB cluster in oral cancer cell lines.
Xavier FC; Destro MF; Duarte CM; Nunes FD
Arch Oral Biol; 2014 Aug; 59(8):783-9. PubMed ID: 24859765
[TBL] [Abstract][Full Text] [Related]
31. WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.
Ribeiro IP; Caramelo F; Marques F; Domingues A; Mesquita M; Barroso L; Prazeres H; Julião MJ; Baptista IP; Ferreira A; Melo JB; Carreira IM
Cell Oncol (Dordr); 2016 Dec; 39(6):573-582. PubMed ID: 27491556
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.
Lai YH; He RY; Chou JL; Chan MW; Li YF; Tai CK
J Transl Med; 2014 Sep; 12():237. PubMed ID: 25179542
[TBL] [Abstract][Full Text] [Related]
33. Assessment of tumor suppressor promoter methylation in healthy individuals.
Poduval DB; Ognedal E; Sichmanova Z; Valen E; Iversen GT; Minsaas L; Lønning PE; Knappskog S
Clin Epigenetics; 2020 Aug; 12(1):131. PubMed ID: 32859265
[TBL] [Abstract][Full Text] [Related]
34. Global analysis of DNA methylation changes during progression of oral cancer.
Towle R; Truong D; Hogg K; Robinson WP; Poh CF; Garnis C
Oral Oncol; 2013 Nov; 49(11):1033-42. PubMed ID: 24035722
[TBL] [Abstract][Full Text] [Related]
35. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
36. Aberrant promoter methylation of T-cadherin in sera is associated with a poor prognosis in oral squamous cell carcinoma.
Wang Q; Chen Y; Chen Y; Jiang J; Song X; Zhang L; He Q; Ye B; Wu L; Wu R; Lai Q; Wang D; Zhao Y
Neoplasma; 2021 May; 68(3):528-534. PubMed ID: 33567853
[TBL] [Abstract][Full Text] [Related]
37. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
[TBL] [Abstract][Full Text] [Related]
38. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.
Foy JP; Pickering CR; Papadimitrakopoulou VA; Jelinek J; Lin SH; William WN; Frederick MJ; Wang J; Lang W; Feng L; Zhang L; Kim ES; Fan YH; Hong WK; El-Naggar AK; Lee JJ; Myers JN; Issa JP; Lippman SM; Mao L; Saintigny P
Cancer Prev Res (Phila); 2015 Nov; 8(11):1027-35. PubMed ID: 26342026
[TBL] [Abstract][Full Text] [Related]
39. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
40. Shared epigenetic alterations between oral cancer and periodontitis: A preliminary study.
Gabusi A; Gissi DB; Grillini S; Stefanini M; Tarsitano A; Marchetti C; Foschini MP; Montebugnoli L; Morandi L
Oral Dis; 2023 Jul; 29(5):2052-2060. PubMed ID: 35567390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]